Latest News & Features
Big Pharma
In a victory for Novartis, the Delhi High Court in India has issued a permanent injunction against two India-based companies which had allegedly sought to make a generic version of the Hepatitis C treatment, Revolade. 19 April 2022
Medtech
A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis. 19 April 2022
Americas
The US Supreme Court has asked the Solicitor General to wade in on a case centring on the legal concept of enablement that is the crux of an antibody patent dispute between Amgen and Sanofi. 19 April 2022
Big Pharma
The ‘joint applicants’ approach to PCT applications would provide an elegant solution to issues of who is entitled to priority claims in PCT applications, suggests Chiara Banas of EIP. 14 April 2022
Generics
New Jersey pharma company Jacobus Pharmaceutical has asked the US Supreme Court to review an 11th Circuit verdict that it claims “eviscerated” decades of precedent regarding Orphan Drug Act exclusivity. 14 April 2022
Americas
GlaxoSmithKline has agreed to acquire California-based biopharma company Sierra Oncology for $1.9 billion, in a move that bolsters the UK company’s cancer business. 14 April 2022
Medtech
A Texas jury has handed a $12 million victory to an Israeli company after finding that Danish company 3Shape’s dental scanner infringed one of its patents. 12 April 2022
Medtech
Abbot-owned St Jude Medical will have to defend claims that its catheters infringe a company’s revived patent. 12 April 2022
Big Pharma
The US Patent Trial and Appeal Board has agreed to review claims of a Seagen patent that Daiichi Sankyo was found to have infringed with its Enhertu breast cancer treatment. 11 April 2022
Generics
Bristol Myers Squibb has sued MSN Laboratories over its planned generic of Pomalyst, which it claims infringes six patents owned by BMS’ subsidiary Celgene. 7 April 2022